Abivax (AAVXF) Non-Current Debt (2022 - 2025)

Abivax has reported Non-Current Debt over the past 3 years, most recently at $35.8 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $35.8 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $35.8 million (changed N/A YoY), and the annual figure for FY2025 was $34.8 million, changed.
  • Non-Current Debt for Q4 2025 was $35.8 million at Abivax, down from $42.7 million in the prior quarter.
  • Over the last five years, Non-Current Debt for AAVXF hit a ceiling of $42.7 million in Q4 2023 and a floor of $3.3 million in Q4 2022.
  • Median Non-Current Debt over the past 3 years was $35.8 million (2025), compared with a mean of $27.3 million.
  • Peak annual rise in Non-Current Debt hit 1183.38% in 2023, while the deepest fall reached 1183.38% in 2023.
  • Abivax's Non-Current Debt stood at $3.3 million in 2022, then soared by 1183.38% to $42.7 million in 2023, then dropped by 16.09% to $35.8 million in 2025.
  • The last three reported values for Non-Current Debt were $35.8 million (Q4 2025), $42.7 million (Q4 2023), and $3.3 million (Q4 2022) per Business Quant data.